Alpha Ketoglutarate Enhances Geroprotection In Surgery (AEGIS)

Recruiting Phase 4 Interventional Study
CABG
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
50 and older
Sex
Any
Trial phase
Phase 4
Study type
Interventional
Purpose
Prevention
Participants needed
250 (estimated)
Sponsor
National University Hospital, Singapore · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
One of the most common major surgeries that older patients undergo is coronary artery bypass grafting surgery (CABG), which is performed in approximately 400,000 patients in the United States each year. CABG invokes a massive surgical stress response, with systemic epinephrine increasing 33-fold and norepinephrine increasing 3-fold. Initially, local tissue injury results in a sterile inflammation,…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria 1. Scheduled for elective CABG with cardiopulmonary bypass 2. Aged 50 years and above 3. Adequate cognitive function to be able to give informed consent Exclusion Criteria 1. Patients already taking AKG as a supplement 2. Substance abuse disorder either untreated or treated 3. …
Contacts

Lian Kah Ti

6567724200

anatilk@nus.edu.sg

CONTACT